Beyond race: Recruitment of diverse participants in clinical genomics research for rare disease

Undiagnosed Diseases Network Consortium

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Purpose: Despite recent attention to increasing diversity in clinical genomics research, researchers still struggle to recruit participants from varied sociodemographic backgrounds. We examined the experiences of parents from diverse backgrounds with enrolling their children in clinical genomics research on rare diseases. We explored the barriers and facilitators parents encountered and possible impacts of sociodemographic factors on their access to research. Methods: We utilized semi-structured interviews with parents of children participating in the Undiagnosed Diseases Network. Interview data were analyzed using comparative content analysis. Results: We interviewed 13 Hispanic, 11 non-Hispanic White, four Asian, and two biracial parents. Participants discussed different pathways to clinical genomics research for rare disease as well as how sociodemographic factors shaped families’ access. Themes focused on variation in: 1) reliance on providers to access research; 2) cultural norms around health communication; 3) the role of social capital in streamlining access; and 4) the importance of language-concordant research engagement. Conclusion: Our findings suggest that variables beyond race/ethnicity may influence access in clinical genomics research. Future efforts to diversify research participation should consider utilizing varied recruitment strategies to reach participants with diverse sociodemographic characteristics.

Original languageEnglish (US)
Article number949422
JournalFrontiers in Genetics
Volume13
DOIs
StatePublished - Aug 22 2022

Keywords

  • equity
  • exome sequencing
  • genome sequencing
  • pediatrics
  • rare disease

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Molecular Medicine

Fingerprint

Dive into the research topics of 'Beyond race: Recruitment of diverse participants in clinical genomics research for rare disease'. Together they form a unique fingerprint.

Cite this